These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 8304818)

  • 1. [Calcium channel antagonists and myocardial ischemia or ischemia/reperfusion].
    Lièvre M; Boissel JP
    Arch Mal Coeur Vaiss; 1993 Jul; 86 Spec No 4():91-8. PubMed ID: 8304818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparison of effects of verapamil and those of nicardipine on myocardial ischemia and reperfusion injury: a study in an in situ rabbit model].
    Furuya M; Yoshida K
    Masui; 1999 Oct; 48(10):1074-82. PubMed ID: 10554498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Calcium antagonists in cardiovascular diseases].
    Thuillez C
    Arch Mal Coeur Vaiss; 1995 Sep; 88 Spec No 4():9-12. PubMed ID: 7503623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium-channel blockers and advanced cardiac life support.
    Weaver WD
    Circulation; 1986 Dec; 74(6 Pt 2):IV94-7. PubMed ID: 3536167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Calcium antagonists in ischemic heart disease].
    Guize L
    J Mal Vasc; 1997 Oct; 22(4):222-8. PubMed ID: 9411006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiarrhythmic and anti-ischemic properties of calcium-channel antagonists.
    Apostolakos MJ; Varon ME
    New Horiz; 1996 Feb; 4(1):45-57. PubMed ID: 8689275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Calcium antagonists in cardiovascular disease. Clinical evidence from morbidity and mortality trials].
    Oparil S; Bakir SE
    Drugs; 2000; 59 Spec No 2():25-37. PubMed ID: 11002856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beneficial effects of diltiazem during myocardial reperfusion: a randomized trial in acute myocardial infarction.
    Pizzetti G; Mailhac A; Li Volsi L; Di Marco F; Lu C; Margonato A; Chierchia SL
    Ital Heart J; 2001 Oct; 2(10):757-65. PubMed ID: 11721720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of calcium antagonists in progression of arteriosclerosis. Evidence from animal experiments and clinical experience. Part II. Clinical experience with preventive effects of calcium channel blockers in atheromatous coronary artery disease.
    Just H; Frey M
    Basic Res Cardiol; 1994; 89 Suppl 1():177-84. PubMed ID: 7945172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Calcium antagonists in the secondary prevention of myocardial infarction].
    Lièvre M; Nony P
    Therapie; 1993; 48 Spec No():677-83. PubMed ID: 8091354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Views on the use of calcium channel blockers in the treatment of heart ischemia and hypertension].
    Halawa B
    Pol Merkur Lekarski; 1998 Sep; 5(27):107-10. PubMed ID: 10101470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Calcium inhibitors and myocardial ischemia].
    Thuillez C
    Therapie; 1993; 48 Spec No():671-6. PubMed ID: 8091353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcium antagonists and experimental myocardial ischemia reperfusion injury.
    Ambrosio G; Villari B; Chiariello M
    J Cardiovasc Pharmacol; 1992; 20 Suppl 7():S26-9. PubMed ID: 1284153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reperfusion injury in humans: a review of clinical trials on reperfusion injury inhibitory strategies.
    Dirksen MT; Laarman GJ; Simoons ML; Duncker DJ
    Cardiovasc Res; 2007 Jun; 74(3):343-55. PubMed ID: 17306241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapeutic measures following acute myocardial infarct: differential use of PTCA, surgery and drugs].
    Noll G; Kaufmann U; Wenzel RR; Lüscher TF
    Schweiz Med Wochenschr; 1996 Feb; 126(5):164-76. PubMed ID: 8685687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Invasive vs non-invasive treatment in acute coronary syndromes and prior bypass surgery.
    Gurfinkel EP; Perez de la Hoz R; Brito VM; Duronto E; Dabbous OH; Gore JM; Anderson FA;
    Int J Cardiol; 2007 Jun; 119(1):65-72. PubMed ID: 17045681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. API expert consensus document on management of ischemic heart disease.
    Association of Physicians of India
    J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evolution of myocardial ischemia therapy: calcium antagonists and ACE-inhibitors].
    Ferrari R
    Cardiologia; 1994 Dec; 39(12 Suppl 1):203-6. PubMed ID: 7634268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning.
    Ferdinandy P; Schulz R; Baxter GF
    Pharmacol Rev; 2007 Dec; 59(4):418-58. PubMed ID: 18048761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of cardiovascular therapy on risk of the development of ischemia and myocardial infarction in the postoperative period in cancer patients with ischemic heart diseases].
    Stetsenko AE; Kassil' VL; Ushakova TI
    Anesteziol Reanimatol; 2001; (5):55-7. PubMed ID: 11757304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.